Buy
Sell
Share Name Share Symbol Market Type Share ISIN Share Description
Bioquell LSE:BQE London Ordinary Share GB0004992003 ORD 10P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  +0.00p +0.00% 597.00p 0.00p 0.00p - - - 0 01:00:00
Industry Sector Turnover (m) Profit (m) EPS - Basic PE Ratio Market Cap (m)
Health Care Equipment & Services 29.2 3.3 11.6 51.5 133.45

BGL Announces the Sale of Bioquell to Ecolab

14/02/2019 2:47pm

PR Newswire (US)


Bioquell (LSE:BQE)
Historical Stock Chart

6 Months : From Dec 2018 to Jun 2019

Click Here for more Bioquell Charts.

CHICAGO, Feb. 14, 2019 /PRNewswire/ -- Brown Gibbons Lang & Company (BGL) is pleased to announce its representation of Bioquell PLC (LSE: BQE) in its sale to Ecolab Inc. (NYSE: ECL). BGL's Healthcare & Life Sciences team served as the exclusive financial advisor to Bioquell in the transaction.  To learn more about BGL's Healthcare & Life Sciences Group, please visit:  www.bglco.com/healthcare-life-sciences.

BGL is pleased to announce its representation of Bioquell PLC (LSE: BQE) in its sale to Ecolab Inc. (NYSE: ECL). BGL’s Healthcare & Life Sciences team served as the exclusive financial advisor to Bioquell in the transaction.

Ecolab acquired 100 percent of the outstanding shares of Bioquell with total consideration payable to shareholders following anticipated option exercises of approximately £139 million ($178 million), subject to determination of the final share count.

Bioquell offers a unique opportunity to broaden Ecolab's portfolio of products, services, and solutions. Bioquell's expertise in bio-decontamination and deep-cleaning utilizing vaporized hydrogen peroxide technologies complements Ecolab's daily cleaning and disinfection offerings for cleanrooms and other high-grade environments. 

About Bioquell
Headquartered in Andover, U.K., Bioquell is a leading provider of hydrogen peroxide vapor bio-decontamination systems and services. Bioquell's innovative bio-decontamination and isolator technologies and services help ensure residue-free surface decontamination in cleanrooms and research and development labs at biotech start-ups, pharmaceutical manufacturers and Fortune 500 companies, and inpatient rooms at hospitals in more than 50 countries. For more information, please visit www.bioquell.com.

About Brown Gibbons Lang & Company
Brown Gibbons Lang & Company is a leading independent investment bank serving the middle market. BGL specializes in mergers and acquisitions advisory services, debt and equity placements, financial restructuring advice, and valuations and fairness opinions, with global industry teams in Consumer, Diversified Industrials, Environmental & Industrial Services, Healthcare & Life Sciences, Metals & Metals Processing, and Real Estate. BGL has offices in Atlanta, Chicago, Cleveland, Denver, Philadelphia, San Antonio, and San Diego, in addition to international offices in more than 50 countries across 5 continents through our Global M&A Partners network. BGL is able to deliver to our clients unparalleled access to strategic relationships, investors, and opportunities globally. For more information, please visit www.bglco.com.

 

(PRNewsfoto/Brown Gibbons Lang & Company)

Cision View original content to download multimedia:http://www.prnewswire.com/news-releases/bgl-announces-the-sale-of-bioquell-to-ecolab-300795912.html

SOURCE Brown Gibbons Lang & Company

Copyright 2019 PR Newswire

1 Year Bioquell Chart

1 Year Bioquell Chart

1 Month Bioquell Chart

1 Month Bioquell Chart
Your Recent History
LSE
BQE
Bioquell
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P: V:gb D:20190620 02:06:32